Tag: Pharmacology

New tuberculosis drug may shorten treatment time for patients

A new experimental antibiotic for tuberculosis has been shown to be more effective against TB than isoniazid, a decades-old drug which is currently one of the standard treatments. In mouse studies, the new drug showed a much lower tendency to develop resistance, and it remains in the tissues where the Mycobacterium tuberculosis bacteria reside for

Drug shows promise to treat diet-induced osteoarthritis

QUT scientists have found that a drug derived from omega-3 fatty acids can reduce osteoarthritis inflammation that’s been caused by a high-fat diet. The study, published in Nature journal Scientific Reports, is among the first to investigate resolvin D1 (RvD1), which has reported anti-inflammatory properties, as a possible treatment for diet-associated osteoarthritis, which affects knees,

Progress against hepatitis C by 2030 is possible

A comprehensive package of prevention, screening, and treatment interventions could avert 15.1 million new hepatitis C infections and 1.5 million cirrhosis and liver cancer deaths globally by 2030 — equal to an 80% reduction in incidence and a 60% reduction in deaths compared with 2015, according to the first study to model hepatitis C interventions

Blocking toxic-protein production in ALS

Patients with ALS frequently have a string of repeated DNA code in the cells of their brain, carrying hundreds to thousands of copies within the gene C9orf72. New research looks at what triggers these repeated sequences to eventually produce the toxic proteins that are associated with ALS, frontotemporal dementia, and other neurodegenerative diseases in patients

Gold-complexed ferrocenyl phosphines as potent antimalarials

A team of researchers from the Singapore University of Technology and Design (SUTD) and Nanyang Technological University (NTU) have developed novel ferrocene-based molecules that impair the malaria parasite’s metabolic function leading to parasite death. Despite concerted efforts for malaria elimination, this deadly disease remains a major health threat to the developing world. The causative agent

Engineers repurpose wasp venom as an antibiotic drug

The venom of insects such as wasps and bees is full of compounds that can kill bacteria. Unfortunately, many of these compounds are also toxic for humans, making it impossible to use them as antibiotic drugs. After performing a systematic study of the antimicrobial properties of a toxin normally found in a South American wasp,

Molecular mechanisms of ancient herbal remedies: Components of leaf extract prove highly effective at preventing life-threatening seizures

Researchers in the Department of Physiology & Biophysics at the University of California, Irvine School of Medicine have discovered the molecular basis for a therapeutic action of an ancient herbal medicine used across Africa to treat various illnesses, including epilepsy. The herbal medicine, a leaf extract from the shrub Mallotus oppositifolius, was previously found to

Potential assay artefacts in anti-malarial screening documented

Malaria remains an economic and health burden to the developing world. As plasmodium, the causative agent of malaria, is acquiring rapid resistance against currently used drugs, identification of new classes of anti-malarials remains an urgent need. Potential anti-malarials include small molecules, peptides, antibodies or plant extracts with likely medicinal properties. These agents are often prepared

Taking out the (life-threatening) garbage: Bacteria eject trash to survive: ‘Minicell’ pods, used in drug delivery, discard damaged proteins to prolong life

Scientists have known for decades that certain bacteria produce small spherical versions of themselves. Although they lack basic materials to reproduce or function like normal cells, recent interest in such “minicells” has spiked due to their proficiency as nano-sized delivery tools for drugs and vaccines to targeted cells and tissues. Yet the natural role of

Cancer drug and antidepressants provide clues for treating brain-eating amoeba infections

The amoeba Naegleria fowleri is commonly found in warm swimming pools, lakes and rivers. On rare occasions, the amoeba can infect a healthy person and cause severe primary amebic meningoencephalitis, a “brain-eating” disease that is almost always fatal. Other than trial-and-error with general antifungal medications, there are no treatments for the infection. Researchers at Skaggs

Sugar pills relieve pain for chronic pain patients: Placebo benefits can be predicted by brain anatomy and psychological traits

Someday doctors may prescribe sugar pills for certain chronic pain patients based on their brain anatomy and psychology. And the pills will reduce their pain as effectively as any powerful drug on the market, according to new research. Northwestern Medicine scientists have shown they can reliably predict which chronic pain patients will respond to a

Superbugs jumping frequently between humans and animals

The MRSA staphylococcus is an example of a pathogen, the likes of which are often called superbugs. These are resistant to most antibiotics and can cause serious infections. “In the case of MRSA, these bacteria have also spread in hospitals almost world-wide,” says Jukka Corander, professor at the University of Helsinki, who was a member

Chest pain drug falls short in preventing first episode of ventricular arrhythmia or death: But, drug found to reduce recurrent ventricular tachycardia in major multi-center trial

A clinical trial of more than 1,000 patients with implantable cardioverter defibrillators (ICDs) found that the drug ranolazine (commonly used to treat chest pain; brand name Ranexa®) was safe but didn’t significantly decrease the likelihood of the first occurrence of ventricular tachycardia, ventricular fibrillation or death in this high-risk population. The study was published recently

A human enzyme can biodegrade graphene

Myeloperoxidase — an enzyme naturally found in our lungs — can biodegrade pristine graphene, according to the latest discovery of Graphene Flagship partners in CNRS, University of Strasbourg (France), Karolinska Institute (Sweden) and University of Castilla-La Mancha (Spain). Among other projects, the Graphene Flagship designs based like flexible biomedical electronic devices that will interfaced with

Neanderthal mother, Denisovan father! Hybrid fossil: Newly-sequenced genome sheds light on interactions between ancient hominins

Together with their sister group the Neanderthals, Denisovans are the closest extinct relatives of currently living humans. “We knew from previous studies that Neanderthals and Denisovans must have occasionally had children together,” says Viviane Slon, researcher at the MPI-EVA and one of three first authors of the study. “But I never thought we would be